{"schema_version":"secwatch.filing_event.v1","accession":"0000896622-23-000014","form_type":"8-K","ticker":"ATR","cik":"0000896622","company_name":"APTARGROUP, INC.","filed_at":"2023-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.713182+00:00","generated_at":"2026-06-17T02:53:33.068334+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AptarGroup realigns segments into Pharma, Beauty, Closures; recasts 2022 & 2021 data","bullets":["Effective Jan 1, 2023: combined all closures into Aptar Closures; renamed Beauty+Home to Aptar Beauty.","FY 2022 net sales $3.32B (up 2.9% YoY); adjusted EBITDA $616.7M vs $607.5M in 2021.","Aptar Closures FY 2022 adjusted EBITDA margin 11.7%, down from 14.3% in 2021.","Aptar Beauty FY 2022 adjusted EBITDA margin 12.4%, up from 10.6% in 2021.","Recast quarterly and annual segment revenue and adjusted EBITDA furnished for 2022 and 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0000896622-23-000014","json":"https://secwatch.observer/filing/0000896622-23-000014.json","markdown":"https://secwatch.observer/filing/0000896622-23-000014.md","text":"https://secwatch.observer/filing/0000896622-23-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896622/000089662223000014/0000896622-23-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896622/000089662223000014/atr-20230413.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T02:53:33.068334+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}